Colorectal cancer: targeting metastasis and angiogenesis.
Chu
Edward
E
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D018450:Disease Progression; D005109:Extracellular Matrix / Q000473:pathology; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D009362:Neoplasm Metastasis; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D011758:Pyrroles / Q000494:pharmacology
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D007211:Indoles; D011758:Pyrroles; C116890:Semaxinib; D020782:Matrix Metalloproteinases